SEARCH
Novo Nordisk record profits with weight-loss-drug demand boost
CGTN Europe
2023-11-02
Views
2
Description
Share / Embed
Download This Video
Report
Fiona Cincotta, Analyst from City Index talks with CGTN Europe on Novo Nordisk Q3 result.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x8paqer" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
04:15
Novo Nordisk reports Q1 profits o $3.65 BN as demand for weightloss drug soars
00:45
Novo Nordisk cuts supply of obesity drug Wegovy in the US due to surging demand
01:52
Ten Pharma Firms Form Non-profit to Speed Up New Drug Trials; InBalance Health Launches New Nutrition Bars; Novo Nordisk Ranks High on Carbon Disclosure Project - Health Minute for September 27, 2012
00:39
Novo Nordisk Shares Pop as New Obesity Drug Candidate Shows Impressive 13.1% Weight Loss in Early Trials
03:24
Novo Nordisk earnings: sales of weight-loss drug Wegovy lower than expected
01:00
Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition
03:37
Streetsmart Marketing Testimonial - From Loss Profits to increase Profits
00:49
Novo Nordisk Boosts 2023 Outlook
00:35
Novo Nordisk Raises Sales Growth Outlook Despite Profit Miss. CEO Predicts 'Attractive Growth' Amidst Competition and Regulation Shifts.
00:42
Weight Loss Bubble? Investors Bullish on Novo Nordisk and Eli Lilly as Obesity Epidemic Drives Sales of Ozempic and Wegovy
01:32
Wegovy heart benefits due to more than weight loss -Novo Nordisk
03:31
Mantis Tiller boosted profits by boosting its guarantee